| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $243.3M | -33.9% |
| Gross Profit | $19.6M | -52.1% |
| R&D Expense | $4.0M | -9.2% |
| SG&A Expense | $9.3M | +0.7% |
| Operating Income | $6.4M | -76.7% |
| Pre-tax Income | $16.3M | -56.4% |
| Income Tax | $792K | — |
| Net Income | $15.5M | -58.5% |
| EPS (Basic) | $0.35 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.5M | -50.1% |
| Inventory | $20.6M | -37.4% |
| Current Assets | $164.8M | -43.3% |
| Total Assets | $247.7M | -32.5% |
| Current Liabilities | $33.3M | -19.4% |
| Total Liabilities | $41.9M | -26.8% |
| Stockholders' Equity | $205.8M | -33.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.8M | +3.4% |
| Capital Expenditures | $14.7M | +143.6% |
| Investing Cash Flow | -$14.8M | -148.8% |
| Financing Cash Flow | -$119.9M | -1040.2% |
| Free Cash Flow | $10.1M | -43.6% |
| -58.8% |
| EPS (Diluted) | $0.35 | -58.8% |